Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer – Alan Bryce

Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan Bryce, MD, Chief Clinical Officer, City of Hope Cancer Center Pheonix, Phoenix, Arizona Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre, Madrid, Spain Related Content: An Overview in…

Read the full article here

Source: www.urotoday.com

Categories: General News, General Medicine News

Tags: ProstateCancer

Tweets with this article

UroToday.com

Real-world evidence informs clinical decision-making in metastatic castration-resistant #ProstateCancer. @AlanBryce9 @cityofhope joins @Ecastromarcos in this discussion as part of an Independent Medical Education Initiative supported by @BayerPharma > https://t.co/W3eCflNlhO https://t.co/wivvWqyWuf

Related Articles

Advanced Imaging for Focal Therapy in Intermediate Risk Prostate Cancer – Matthew Cooperberg

Zachary Klaassen speaks with Matthew Cooperberg about the integration of OnQ™ Prostate assisted Focal One® Robotic HIFU for prostate cancer treatment. Dr. Cooperberg discusses how…

UroToday.com June 14, 2025

The Art of the Pivot | Hopkins Bloomberg Public Health Magazine

Pandemics. Wars. Existential financial threats. The Bloomberg School has long used its hard-won experience to anticipate and shape the future.

JHU Public Health June 14, 2025

Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects

To identify regulatory variants with plasticity in effect size, we performed interaction molecular quantitative trait loci (iQTL) mapping with cell-type abundance, age, sex, and smoking…

Cell Press June 14, 2025

India’s Sun Pharma names Kirti Ganorkar as managing director

Sun Pharmaceutical , India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1.

Reuters Health June 13, 2025

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT June 13, 2025

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

pharmalot June 13, 2025

Combining Alpha and Beta Emitters in PSMA-Targeted Prostate Cancer Therapy – Scott Tagawa

Pedro Barata interviews Scott Tagawa about radioligand therapy research, focusing on actinium-225 PSMA antibody constructs. Dr. Tagawa explains that antibodies like rosopatamab offer advantages over…

UroToday.com June 13, 2025

The stakes of RFK Jr.’s decision to remake a vaccine panel are life and death

Take a moment to consider the stakes involved in health secretary Robert F. Kennedy’s remake of a vaccine advisory committee.

STAT June 13, 2025

Maximizing Equipment Uptime with Predictive Maintenance Technologies – MedCity News

In the past, arbitrary maintenance schedules and planned downtime were necessary expenses. Now we have the tools to think and work differently

MedCity News June 13, 2025

MedCity INVEST Digital Health

MedCity News INVEST digital health unites investors, start-ups and industry leaders within the healthcare industry.

MedCity News June 13, 2025